Nov 10 (Reuters) - miRagen Therapeutics Inc :
* MIRAGEN REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
* Q3 LOSS PER SHARE $0.10
* Q3 EARNINGS PER SHARE ESTIMATE $-0.13 -- REFINITIV IBES DATA
* PLANS TO EFFECT A REVERSE STOCK SPLIT OF ITS SHARES OF COMMON STOCK AT A RATIO OF 1-FOR-15
* ANTICIPATES STOCK SPLIT WILL BE EFFECTIVE AS OF NOVEMBER 12, 2020
* TRADING OF COMMON STOCK WILL BEGIN ON A SPLIT-ADJUSTED BASIS WHEN MARKETS OPEN ON NOVEMBER 13, 2020
Source text for Eikon: Further company coverage:
((reuters.briefs@thomsonreuters.com;))